Tookad publications

2006

WOODHAMS J.H.; MACROBERT A.J.; NOVELLI M.; BOWN S.G.: Photodynamic Therapy with WST09 (Tookad) – quantitative studies in normal colon and transplanted tumours. INT. J. CANCER 2006, 118: 477-82.

2005

DOLE K.C.; CHEN Q.; HETZEL F.W.; WHALEN L.R.; HUANG Z.: Effects of photodynamic therapy on peripheral nerve: In situ compound-action potentials study in a canine model. PHOTOMED. LASER SURGERY, 2005, 23 (2), pp: 172-6.

HUANG Z.; CHEN Q.; LUCK D.; BECKERS J.; WILSON B.C.; TRNCIC N.; LARUE S.M.; BLANC D.; HETZEL F.W.: Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer. LASERS SURGERY MEDICINE, 2005, 36: 390-97.

HUANG Z.; CHEN Q.; LUCK D.; BECKERS J.; BLANC D.; HETZEL F.W.: Tookad-mediated photodynamic effects on the prostate and its adjacent tissues- in vivo study in canine models. SPIE PROCEEDINGS, 2005 (5689), pp: 106-11.

VAKRAT-HAGLILI Y.; WEINER L.; BRUMFELD V.; BRANDIS A.; SALOMON Y.; MCLLROY B.; WILSON B.C.; PAWLAK A.; ROZANOWSKA M.; SARNA T.; SCHERZ A.: The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J. AM. CHEM. SOC., 2005, May 4; 127(17): pp: 6487-6497.

WEERSINK R.A.; FORBES J.; BISLAND S.; TRACHTENBERG J.; ELHILALI M.; BRUN P.H.; WILSON B.C.: Assessment of Cutaneous Photosensitivity of TOOKAD (WST09) in Preclinical Animal Models and in patients. PHOTOCHEM. PHOTOBIOLOGY, 2005, 81(1), pp: 106-13.

WOODHAMS J.H.; MacROBERT A.J.; NOVELLI M.; BOWN S.G.: Photodynamic Therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours. INT. J. CANCER, 2006, 118, pp: 477-82.

2004

BRUN P.H.; BUCKING M.; DEGROOT J.L.; DICKSON E.F.; FARAHANI M.; POTTIER R.H.: Neutron activation and liquid scintillation analysis of tissue samples containing palladium bacteriochlorophyll derivative, a potential photochemotherapeutic agent. CAN. J. AN. SCI. SPECTR., 2004, 49(2), pp: 55-63.

BRUN P.H.; DEGROOT J.L.; GUDGIN DICKSON E.F.; FARAHANI M.; POTTIER R.H.: Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing balb/c mice using graphite furnace atomic absorption spectroscopy. PHOTOCHEM. PHOTOBIOL. SCI., 2004, 3(11-12), pp: 1006-10.

GARBO G.M.; KIK P.K.; HARRISON L.T.; BRUN P.H.; BLANC D.; PAULIN P.S.; WIEMAN T.J.; FINGAR V.H.: Differential vascular response and relationship to tumor response with photodynamic therapy using WST-09 (TOOKAD). SPIE PROCEEDINGS, 2004 (5315), pp: 18-26.

HETZEL F.W.; CHEN Q.; LUCK D.; BECKERS J.; HUANG Z.: Preclinical studies of vascular acting photosensitizer bacteriopheophorbide for the treatment of prostate cancer. SPIE PROCEEDINGS, 2004 (5315), pp: 27-32.

HUANG Z.; CHEN Q.; TRNCIC N.; LARUE S.M.; BRUN P.H.; WILSON B.C.; SHAPIRO H.; HETZEL F.W.: Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation. RADIATION RESERACH, 2004, 161(6), pp: 723-31.

KELLEHER D.K.; THEWS O.; SCHERZ A.; SALOMON Y.; VAUPEL P.: Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide. INT. J. ONCOL., 2004, 24(6), pp: 1505-11.

PLAKS V.; KOUDINOVA N.; NEVO U.; PINTHUS J.H.; KANETY H.; ESHHAR Z.; RAMON J.; SCHERZ A.; NEEMAN M.; SALOMON Y.: Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: A biphasic apparent diffusion coefficient change as potential early MRI response marker. NEOPLASIA, 2004, 6(3), pp: 224-33.

WEERSINK R.A.; BOGAARDS A.; GERTNER M.; DAVIDSON S.; ZHANG K.; NETCHEV G.; GIEWERCER D.; TRACHTENBERG J.; WILSON B.C.: Optical delivery and monitoring of photodynamic therapy of prostate cancer. SPIE PROCEEDINGS, 2004 (5578), pp: 117-27.

2003

BORLE F.; RADU A.; FONTOLLIET C.; VAN DEN BERGH H.; MONNIER P.; WAGNIERES G.: Selectivity of the photosensitizer Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumor model. BR. J. CANCER, 2003, 89(12), pp: 2320-26.

BORLE F.; RADU A.; MONNIER P.; VAN DEN BERGH H.; WAGNIERES G.: Evaluation of the photosensitizer Tookad (WST09) for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects. PHOTOCHEM. PHOTOBIOLOGY, 2003, 78(4), pp: 377-83.

CHEN Q.; HUANG Z.; LUCK D.; BECKERS J.; TRNCIC N.; LARUE S.M.; BRUN P.H.; WILSON B.C.; HETZEL F.W.: Effects of TOOKAD-PDT on canine prostates pre-treated with ionizing radiation. SPIE PROCEEDINGS, 2003 (4952), pp: 115-24.

GROSS S.; GILEAD A.; SCHERZ A.; NEEMAN M.; SALOMON Y.: Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. NATURE MEDICINE, 2003, 9(10), pp: 1327-31.

HUANG Z.; CHEN Q.; BRUN P.H.; WILSON B.C.; SCHERZ A.; SALOMON Y.; LUCK D.L.; BECKERS J.; HETZEL F.W.: Studies of a novel photosensitizer palladium-bacteriopheophorbide (Tookad) for the treatment of prostate cancer. SPIE PROCEEDINGS, 2003 (4952), pp: 104-14.

HUANG Z.; CHEN Q.; BRUN P.H.; WILSON B.C.; SCHERZ A.; SALOMON Y.; LUCK D.; BECKERS J.; HETZEL F.W.: Studies of a novel photosensitizer Pd-bacteriopheophorbide (Tookad) for the prostate cancer PDT in canine model. SPIE PROCEEDINGS, 2003 (5254), pp: 83-90.

KOUDINOVA N.V.; PINTHUS J.H.; BRANDIS A.; BRENNER O.; BENDEL P.; RAMON J.; ESHHAR Z.; SCHERZ A.; SALOMON Y.: Photodynamic therapy with Pd-bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts. INT. J. CANCER, 2003, 104(6), pp: 782-89.

PREISE D.; MAZOR O.; KOUDINOVA N.; LISCOVITCH M.; SCHERZ A.; SALOMON Y.: Bypass of tumor drug resistance by antivascular therapy. NEOPLASIA, 2003, 5(6), pp: 475-80.

TREMBLAY A.; LEROY S.; FREITAG L.; COPIN M.C.; BRUN P.H.; MARQUETTE C.H.: Endobronchial phototoxicity of WST09 (Tookad), a new fast-acting photosensitizer for photodynamic therapy: Preclinical study in the pig. PHOTOCHEM. PHOTOBIOLOGY, 2003, 78(2), pp: 124-30.

2002

CHEN Q.; HUANG Z.; LUCK D.; BECKERS J.; BRUN P.H.; WILSON B.C.; SCHERZ A.; SALOMON Y.; HETZEL F.W.: WST09 (TOOKAD) mediated photodynamic therapy as an alternative modality in treatment of prostate cancer. SPIE PROCEEDINGS, 2002 (4612), pp: 29-39.

CHEN Q.; HUANG Z.; LUCK D.; BECKERS J.; BRUN P.H.; WILSON B.C.; SCHERZ A.; SALOMON Y.; WETZEL F.W.: Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. PHOTOCHEM. PHOTOBIOLOGY, 2002, 76(4), pp: 438-45.

SCHREIBER S.; GROSS S.; BRANDIS A.; HARMELIN A.; ROSENBACH-BELKIN V.; SCHERZ A.; SALOMON Y.: Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-Bacteriopheophorbide leads to decreased metastases and increase of animal cure compared to surgery. INT. J. CANCER, 2002, 99(2), pp: 279-85.

WEERSINK R.A.; WILSON B.C.; PATTERSON M.S.: Determination of the peak absorption wavelength and disaggregation kinetics of TOOKAD in vivo using dynamic, spatially resolved diffuse reflectance spectroscopy in a rabbit model. SPIE PROCEEDINGS, 2002 (4613), pp: 135-42.